Global Liver Fibrosis Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Liver Fibrosis Drug

• 1.1 Definition of Liver Fibrosis Drug
• 1.2 Liver Fibrosis Drug Segment by Type
  • 1.2.1 Global Liver Fibrosis Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Interferon
  • 1.2.3 Maloti Lipid
  • 1.2.4 Nucleoside
  • 1.2.5 Other
• 1.3 Liver Fibrosis Drug Segment by Applications
  • 1.3.1 Global Liver Fibrosis Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Research Center
  • 1.3.3 Hospital
  • 1.3.4 Clinic
• 1.4 Global Liver Fibrosis Drug Overall Market
  • 1.4.1 Global Liver Fibrosis Drug Revenue (2014-2025)
  • 1.4.2 Global Liver Fibrosis Drug Production (2014-2025)
  • 1.4.3 North America Liver Fibrosis Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Liver Fibrosis Drug Status and Prospect (2014-2025)
  • 1.4.5 China Liver Fibrosis Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Liver Fibrosis Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Liver Fibrosis Drug Status and Prospect (2014-2025)
  • 1.4.8 India Liver Fibrosis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Liver Fibrosis Drug
• 2.3 Manufacturing Process Analysis of Liver Fibrosis Drug
• 2.4 Industry Chain Structure of Liver Fibrosis Drug

3 Development and Manufacturing Plants Analysis of Liver Fibrosis Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Liver Fibrosis Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Liver Fibrosis Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Liver Fibrosis Drug Production and Capacity Analysis
• 4.2 Liver Fibrosis Drug Revenue Analysis
• 4.3 Liver Fibrosis Drug Price Analysis
• 4.4 Market Concentration Degree

5 Liver Fibrosis Drug Regional Market Analysis

• 5.1 Liver Fibrosis Drug Production by Regions
  • 5.1.1 Global Liver Fibrosis Drug Production by Regions
  • 5.1.2 Global Liver Fibrosis Drug Revenue by Regions
• 5.2 Liver Fibrosis Drug Consumption by Regions
• 5.3 North America Liver Fibrosis Drug Market Analysis
  • 5.3.1 North America Liver Fibrosis Drug Production
  • 5.3.2 North America Liver Fibrosis Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Liver Fibrosis Drug Import and Export
• 5.4 Europe Liver Fibrosis Drug Market Analysis
  • 5.4.1 Europe Liver Fibrosis Drug Production
  • 5.4.2 Europe Liver Fibrosis Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Liver Fibrosis Drug Import and Export
• 5.5 China Liver Fibrosis Drug Market Analysis
  • 5.5.1 China Liver Fibrosis Drug Production
  • 5.5.2 China Liver Fibrosis Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Liver Fibrosis Drug Import and Export
• 5.6 Japan Liver Fibrosis Drug Market Analysis
  • 5.6.1 Japan Liver Fibrosis Drug Production
  • 5.6.2 Japan Liver Fibrosis Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Liver Fibrosis Drug Import and Export
• 5.7 Southeast Asia Liver Fibrosis Drug Market Analysis
  • 5.7.1 Southeast Asia Liver Fibrosis Drug Production
  • 5.7.2 Southeast Asia Liver Fibrosis Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Liver Fibrosis Drug Import and Export
• 5.8 India Liver Fibrosis Drug Market Analysis
  • 5.8.1 India Liver Fibrosis Drug Production
  • 5.8.2 India Liver Fibrosis Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Liver Fibrosis Drug Import and Export

6 Liver Fibrosis Drug Segment Market Analysis (by Type)

• 6.1 Global Liver Fibrosis Drug Production by Type
• 6.2 Global Liver Fibrosis Drug Revenue by Type
• 6.3 Liver Fibrosis Drug Price by Type

7 Liver Fibrosis Drug Segment Market Analysis (by Application)

• 7.1 Global Liver Fibrosis Drug Consumption by Application
• 7.2 Global Liver Fibrosis Drug Consumption Market Share by Application (2014-2019)

8 Liver Fibrosis Drug Major Manufacturers Analysis

• 8.1 Bird Rock Bio, Inc.
  • 8.1.1 Bird Rock Bio, Inc. Liver Fibrosis Drug Production Sites and Area Served
  • 8.1.2 Bird Rock Bio, Inc. Product Introduction, Application and Specification
  • 8.1.3 Bird Rock Bio, Inc. Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bristol-Myers Squibb Company
  • 8.2.1 Bristol-Myers Squibb Company Liver Fibrosis Drug Production Sites and Area Served
  • 8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.2.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Celgene Corporation
  • 8.3.1 Celgene Corporation Liver Fibrosis Drug Production Sites and Area Served
  • 8.3.2 Celgene Corporation Product Introduction, Application and Specification
  • 8.3.3 Celgene Corporation Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Dicerna Pharmaceuticals, Inc.
  • 8.4.1 Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Production Sites and Area Served
  • 8.4.2 Dicerna Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.4.3 Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Digna Biotech, S.L.
  • 8.5.1 Digna Biotech, S.L. Liver Fibrosis Drug Production Sites and Area Served
  • 8.5.2 Digna Biotech, S.L. Product Introduction, Application and Specification
  • 8.5.3 Digna Biotech, S.L. Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Genfit SA
  • 8.6.1 Genfit SA Liver Fibrosis Drug Production Sites and Area Served
  • 8.6.2 Genfit SA Product Introduction, Application and Specification
  • 8.6.3 Genfit SA Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Gilead Sciences, Inc.
  • 8.7.1 Gilead Sciences, Inc. Liver Fibrosis Drug Production Sites and Area Served
  • 8.7.2 Gilead Sciences, Inc. Product Introduction, Application and Specification
  • 8.7.3 Gilead Sciences, Inc. Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 GNI Group Ltd.
  • 8.8.1 GNI Group Ltd. Liver Fibrosis Drug Production Sites and Area Served
  • 8.8.2 GNI Group Ltd. Product Introduction, Application and Specification
  • 8.8.3 GNI Group Ltd. Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 HEC Pharm Co., Ltd.
  • 8.9.1 HEC Pharm Co., Ltd. Liver Fibrosis Drug Production Sites and Area Served
  • 8.9.2 HEC Pharm Co., Ltd. Product Introduction, Application and Specification
  • 8.9.3 HEC Pharm Co., Ltd. Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Dr. Falk Pharma GmbH
  • 8.10.1 Dr. Falk Pharma GmbH Liver Fibrosis Drug Production Sites and Area Served
  • 8.10.2 Dr. Falk Pharma GmbH Product Introduction, Application and Specification
  • 8.10.3 Dr. Falk Pharma GmbH Liver Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 LG Life Science LTD.
• 8.12 Nitto Denko Corporation
• 8.13 Pfizer Inc.
• 8.14 Pharmaxis Limited
• 8.15 Promedior, Inc.
• 8.16 Dynavax Technologies Corporation
• 8.17 Evotec AG
• 8.18 FibroGen, Inc.

9 Development Trend of Analysis of Liver Fibrosis Drug Market

• 9.1 Global Liver Fibrosis Drug Market Trend Analysis
  • 9.1.1 Global Liver Fibrosis Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Liver Fibrosis Drug Regional Market Trend
  • 9.2.1 North America Liver Fibrosis Drug Forecast 2019-2025
  • 9.2.2 Europe Liver Fibrosis Drug Forecast 2019-2025
  • 9.2.3 China Liver Fibrosis Drug Forecast 2019-2025
  • 9.2.4 Japan Liver Fibrosis Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Liver Fibrosis Drug Forecast 2019-2025
  • 9.2.6 India Liver Fibrosis Drug Forecast 2019-2025
• 9.3 Liver Fibrosis Drug Market Trend (Product Type)
• 9.4 Liver Fibrosis Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Liver Fibrosis Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List